Table 1.
Key features of pathological vs. physiological hypertrophy and their mitochondrial alterations
| Physiological hypertrophy | Pathological hypertrophy | |
|---|---|---|
| Stimuli | Volume overload (isotonic exercise) | Volume overload (valvular disease, aortovenous fistula) |
| Pressure overload (isometric exercise) | Pressure overload (arterial hypertension, aortic constriction) | |
| Pregnancy | ||
| Foetal gene expression | Normal | Up-regulated |
| Cardiac function | Normal/improved | Increasingly impaired during the time course |
| Decompensation | Not occuring | Occuring |
| Cardiac structure | Increased myocyte volume | Increased myocyte volume |
| Formation of new sarcomers | Formation of new sarcomers | |
| Interstitial fibrosis | ||
| Increased rates of apoptosis | ||
| Fatty acid oxidation | Unchanged or increased | Decreased |
| Glucose oxidation | Unchanged or increased | Unchanged |
| Maybe reduced during heart failure | ||
| Mitochondrial biogenesis | In accordance to cellular hypertrophy | Unchanged during compensated hypertrophy |
| Maybe diminished during heart failure | ||
| ATP production | Sufficient | Impaired |